CN109709336A - A kind of detection kit and detection method of vascular endothelial growth factor - Google Patents
A kind of detection kit and detection method of vascular endothelial growth factor Download PDFInfo
- Publication number
- CN109709336A CN109709336A CN201811608343.0A CN201811608343A CN109709336A CN 109709336 A CN109709336 A CN 109709336A CN 201811608343 A CN201811608343 A CN 201811608343A CN 109709336 A CN109709336 A CN 109709336A
- Authority
- CN
- China
- Prior art keywords
- vegf
- growth factor
- vascular endothelial
- endothelial growth
- detection kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention discloses a kind of vascular endothelial growth factor detection kit and detection method, kit of the invention includes: VEGF antibody, the VEGF standard items, chemiluminescence preexciting liquid, chemiluminescence exciting liquid, cleaning solution of the magnetic particle of Streptavidin coupling, the VEGF antibody of biotin labeling, chemiluminescent labels label.It is detected using the kit, high sensitivity, reaction time are short, easy to operate, have a good application prospect.
Description
Technical field
The present invention relates to a kind of protein immunization detection methods, are used for blood vessel endothelium based on electrochemical luminescence principle about one kind
The kit and method of growth factor (VEGF) detection.
Background technique
Growth, the transfer of tumour cell rely on the formation of new vessels, vascular endothelial growth factor (vascular
Endothelial growth factor, VEGF) it is most effective angiogenic growth factor
(Ferraraetal.Endocr.Rev.1997,18:4-25).Vascular endothelial growth factor is that recent researches are relatively broad
A kind of completely new broad-spectrum tumor marker (Cancer biomarker), it is considered to be the label of most significant neoplastic hematologic disorder screening
Object.There are four big functions according to the research achievement of our company and external document report vascular endothelial growth factor detection kit:
VEGF peripheral blood cell counts can be used as auxiliary diagnosis (Kondo S, the Biochim Biophys of the screening of (1) tumour, (2) tumour
Acta.1994Mar 31;1221 (2): 211-4), the assessment of (3) oncotherapy curative effect and monitoring, (4) tumor prognosis, Yi Jifu
Hair monitoring (Marpg D Clin Cancer Res April2,2013;DOI:10.1158/1078-0432.CCR-12-
3409)。
VEGF relative molecular weight is 45kDa, is the glycoprotein dimer connected by disulfide bond, other areas by same N-terminal
Domain is made of two polypeptide chains of certain differences.VEGF gene is located at chromosome 6p21.3, which cuts by transcriptional level
It cuts, can produce 5 kinds of different transcriptons, be separately encoded 23,121,165,186 and 206 amino acid polypeptides, VEGF is a kind of allusion quotation
The exocrine protein of type.The monomer that VEGF is decomposed is inactive, removes 2 glycosyl of N to biological effect without influence, but may be in cell
It works in secretion.Vegf gene is made of 8 exons and 7 intrones, is positioned at chromosome
6p21.3, due to exon shearing difference and form different hypotypes, produce respectively VEGF121, VEGF145,
At least five kinds of protein forms such as VEGF165, VEGF185, VEGF206, wherein VEGF121, VEGF145, VEGF165 are secreting types
Soluble protein is expressed in the mankind, can be directly acted on vascular endothelial cell and be promoted vascular endothelial cell proliferation, increase blood vessel
Permeability.
The research of labelling immunoassay technology and application development are rapid nearly ten years, are widely used to biomedical basis
Theoretical research and each field of clinical disease diagnosis.Method for detecting serological index is mainly immune including radioactive isotope
Analysis, enzyme linked immunosorbent assay and chemiluminescence immune assay.These methods both can be used as Primary Screening Test and can also be used as really
Recognize test, wherein chemoluminescence method has many advantages, such as to detect that the range of linearity is wide, detecting instrument is simple and convenient to operate.
Chinese patent 201510115025.0 discloses a kind of vascular endothelial growth factor detection kit and its raw material system
It is standby, it discloses and is coated with Streptavidin, biotinylated VEGF monoclonal antibody is added, it is affine with being formed after antigen-reactive in sample
Element-Antibody-antigen complex adds the VEGF monoclonal antibody of another plant of HRP enzyme label, and it is anti-to ultimately form Avidin-Biotinization
Body-antigen-HRP labelled antibody compound.The detection luminous intensity but realized using this method is not high enough, influences detection effect
Fruit.
Summary of the invention
The purpose of the present invention is to provide a kind of vascular endothelial growth factor detection kit and detection method, luminous intensities
It is high, easy to operate, it has a good application prospect.
A kind of detection kit of vascular endothelial growth factor, comprising: magnetic particle, the biotin of Streptavidin coupling
VEGF antibody, the VEGF standard items, chemiluminescence preexciting liquid, chemistry that VEGF antibody, the chemiluminescent labels of label mark
Shine exciting liquid, cleaning solution.
Preferably, the chemiluminescent labels are acridinium ester or acridine ester derivant, and the acridine ester derivant includes
Acridinium ester acid-NHS ester, acridinic acid propane sulfonic acid sodium salt or 9- azetidinecarboxylic acid.
Preferably, the chemiluminescence preexciting liquid is the ethyl alcohol containing mass percent 0.1-1% and quality percentage
The mass fraction of Triton X-100 and/or Tween-20 than 0.1-1% are the H of 0.1-1%2O2Solution, the chemiluminescence
Exciting liquid be the ethyl alcohol containing mass percent 0.1-1% and mass percent 0.1-1% Triton X-100 and/or
The molar concentration of Tween-20 is the NaOH solution of 0.05-1mol/L.
Preferably, the magnetic particle of Streptavidin coupling by pH be 6-8, molar concentration 0.01-0.2mol/L
Phosphate buffer or Tris buffer form, partial size be 0.05-2 μm.
It is highly preferred that the magnetic particle kernel is ferroso-ferric oxide or di-iron trioxide, the surface modification of magnetic particle
Group is carboxyl.
Preferably, the VEGF standard items are that it is (excellent that VEGF antigen sterling is added using bovine serum albumin(BSA) buffer as solvent
It selects purity to be not less than 90%) to be formulated.
It is highly preferred that the VEGF standard items are the VEGF standard items with multiple concentration gradients being made into.
Preferably, the cleaning solution includes the Triton X-100 and/or Tween 20, pH of mass percent 0.5-10%
The phosphate buffer or Tris buffer for being 0.1-0.5mol/L for 6-8, molar concentration, mass percent 0.5-5%'s
Proclin 300。
The present invention also provides the detection methods using mentioned reagent box, comprising:
(1) the VEGF antibody for taking VEGF antibody, sample to be tested, the chemiluminescent labels of biotin labeling to mark is in anti-
It answers in container, mixes well, and in 37 DEG C of 10~30min of incubation, while preparing standard items;
(2) into reaction system be added Streptavidin coupling magnetic particle, mix well, and in 37 DEG C be incubated for 3~
10min, rear cleaning separation magnetic particle;The mixed of chemiluminescence preexciting liquid and chemiluminescence exciting liquid is added in magnetropism particle
Solution is closed, reacts and measures luminous intensity;
(3) standard curve is drawn according to standard concentration and luminous intensity, sample luminous intensity is corresponding on standard curve
Concentration value is the measurement concentration of sample to be tested.
Beneficial effects of the present invention are as follows:
(1) present invention selects magnetic particle to provide not only as reaction carriers using the detection architecture of electrochemical luminescence
It is a kind of close to homogeneous reaction system, and overcome the technological deficiency of existing enzyme-linked immunization.
(2) present invention selects acridinium ester or derivatives thereof as marker, and reaction does not need catalyst, as long as alkaline environment
Can carry out, be swift in response, can the photon that generates of catching reaction completely, background luminescence is low, and signal-to-noise ratio is high, and disturbing factor is few,
Reagent stability is good, and system is simple, and exciting liquid is at low cost.
(3) present invention adds ethyl alcohol as stabilizer in chemiluminescence preexciting liquid and chemiluminescence exciting liquid, adds
Add TritonX-100 or Tween-20 as reinforcing agent, can effectively enhance the luminous intensity of acridinium ester or derivatives thereof, together
When also can be reduced luminescent system and the chance of bubble occur;The present invention also increases 300 preservative of Proclin in cleaning solution, can
Conducive to further maintenance electrode.
(4) present invention is realized by full-automatic electrochemical luminescence immune detection system, and the addition of reagent and sample is equal
It is completed by instrument, the operation is more convenient, reduces artificial error.
Specific embodiment
Below by specific embodiment, the present invention is described in detail, but the purposes of these exemplary embodiments and
Purpose is only used to enumerate the present invention, not constitutes any type of any restriction to real protection scope of the invention, more non-to incite somebody to action
Protection scope of the present invention is confined to this.
Reagent used in the following embodiment, such as no special explanation, can be from buying on the market.
Embodiment
The invention mainly includes steps:
(1) preparation of monoclonal antibody
1, the expression and purification of VEGF165 fusion protein
1) it is complete that people VEGF 165 building of VEGF gene cloning and prokaryotic expression plasmid: is chosen from human placenta cDNA library
Long sequence pGEX-4T-1 is as carrier, which contains glutathione S-transferase label, and the expression of albumen is by tac promoter control
System.Tac promoter is induced by IPTG.Cloning site chooses EcoRI and NotI.
2) VEGF expressing fusion protein: pGEX-4T-1/VEGF165 is converted to BL21 (DE3) pLysS competent cell
(Escherichia coli), are stablized and efficient expression strain.LB culture medium culture, 37 DEG C of expression GST-VEGF165 fusion protein packets
Contain body.
3) VEGF165 fusion protein purification: recombinant is induced in LB liquid medium through IPTG, is expressed 2 hours
Afterwards, thallus is collected, after ultrasonication, Sarkosyl is added, mixes.Fusion protein supernatant will be contained, Glpgtathione is added
After rinsing, reduced glutathione elution is added in Sepharose 4B gel.Collect albumen.50% glycerin storage in-
20℃。
2, mouse immune and monoclonal antibody preparation
1) it mouse immunization protocol: selects 6-8 week old female BALA/c mouse to be immunized in three times, antigen: using large intestine
Bacillus source VEGF;Immunologic adjuvant uses Freund's adjuvant;Immunization ways: subcutaneous multi-point injection and intraperitoneal injection, primary immunization;
Subcutaneous multi-point injection after 20 μ g of VEGF antigen and adjuvant are fully emulsified;Secondary immunity: with behind primary immunization interval 3 weeks, VEGF is anti-
Subcutaneous multi-point injection (avoiding primary immunization injection point), is immunized: three times between secondary immunity after 20 μ g of original and adjuvant are fully emulsified
Every after two weeks, 20 μ g of VEGF antigen and adjuvant it is fully emulsified after intraperitoneal injection.
2) bioactivity: 10-14 days venous blood samplings after being immunized three times detect antibody titer, reach 106It is above to carry out cell
Fusion.
3) cell fusion
3-1) prepared by myeloma cell: 30 days or so the recovery myeloma cell strains before doing cell fusion use RPMI-1640
Culture medium culture to state it is preferable after, then in the miscellaneous azaguanine of 8- (8-AG) culture medium culture culture 1 week, after use instead again
Solid tumor is beaten to mouse after RPMI-1640 culture medium culture 3-4 days.Neck is drawn to put to death taking-up mouse within 12-18 days after beating oncocyte
Oncocyte, oncocyte are ground after taking out, and are being isolated and purified with lymphocyte separation medium and to cell count;
3-2) the preparation of splenocyte
Immunized mice plucks eyeball execution, takes spleen, grinds, and counts to splenocyte.
3-3) oncocyte is merged with splenocyte
Splenocyte and oncocyte are merged in the ratio of cell count 5: 1, are induced using PEG1200, are added to and complete after fusion
96 orifice plate culture 5-7 days of feeder layer, after measured with HAT culture medium half and change liquid, CLIA method screens positive cell strain.
3-4) cloning and cell determine pearl
Cloning method: limiting dilution assay, the positive cell strain selected carry out limiting dilution, repeatedly 2-3 limiting dilution,
The cell of 95% or more positive rate of selection determines pearl, and cultivates amplification freeze-stored cell strain
3-5) monoclonal antibody is cultivated
Select 6-8 week old female BALA/c mouse peritoneal injection 107A cell for having determined pearl, takes mouse ascites in 5-10 days,
Supernatant is taken after ascites centrifugation,
It is 3-6) monoclonal antibody-purified
Select GE company proteinG purification column;Purification column is balanced with 20mM PB buffer, ascites loading is added, is used
PH2.70.1mol glycine HCI buffer is eluted, and is collected with the EP pipe containing PH8.71mol tris buffer,
0.05mM PB dialysis, concentration freeze.
3-7) monoclonal antibody Property Identification: Property Identification is detected including the use of Sigma CLIA antibody typing reagent.It is single
Anti-cell strain supernatant detects antibody specificity using immunoblotting analysis test and competitive assay.Utilize competition CLIA detection antibody parent
And power.
(2) preparation of the magnetic particle of Streptavidin coupling
1, by 10mL iron oxide (Fe3O4) nanoparticle (partial size is about 1.5 μm) is dissolved in isometric pH 6.0,
In 0.05mol/L borate buffer solution, 1- ethyl-(the 3- diformazan for being 150: 1 with the molar ratio of ferric oxide nano particles is added
Base aminopropyl) phosphinylidyne diimine and N- hydroxy thiosuccinimide, 37 DEG C are reacted 2.5 hours, by iron oxide nano-granule
Sublist face converting carboxylate groups are the active ester of stable under acidic conditions.
2, the solution of streptavidin for being 10: 1 with ferric oxide nano particles molar ratio is added, is adjusted with 1M NaOH solution
PH value of solution reacts at room temperature 3 hours to 8.5, Streptavidin is coupled to ferric oxide nano particles surface.
3, final concentration of 3% single-ended amino polyethylene glycol (HO-PEG-NH is added into solution3), by solution ph
It adjusts to 5.0,18000rpm (28,000g-30,000g), 4 DEG C of centrifugation 30min, abandons supernatant, precipitating pH is 6.8, concentration
For the Tris buffer of 0.1mol/L, to be resuspended to concentration be 0.5mg/mL, and the buffer contains the bovine serum albumin of 0.5wt%
White, 0.05wt% TritonX-100,0.05%proclin300 and 0.05% Sodium azide.
(3) the VEGF Antibody preparation of biotin labeling
400 μ L5mg/mL VEGF monoclonal antibodies are taken, are stirred at 2-8 DEG C with 0.1mol/L, pH9.3 carbonate buffer solution
Dialysis 8 hours is mixed, a not good liquor is changed in centre;Antibody of the ratio for being 1: 25 according to antibody molecule and biotin molecule ratio after dialysis
Biotin solution is added in solution, and DMSO to final concentration of 10% is added, mixes;Slow oscillation, 37 DEG C are protected from light 2h;Add
Enter the 3mol/L ethanolamine solutions of 80 μ L, room temperature is protected from light 30min;Stir dialysis at 2-8 DEG C with 0.01M PBS solution, 6
Hour changes a not good liquor, changes altogether liquid 3 times;Isometric glycerol is added to the antibody-solutions after dialysis, mixes, packing, concentration is
0.5mg/mL, -20 DEG C of preservations.
(4) preparation of the VEGF antibody of acridinium ester label
50 μ L5mg/mL VEGF monoclonal antibodies are taken, the carbonate buffer solution of 150 μ L0.05M pH 9.3 is added, are mixed,
Then the acridinium ester that 5 μ L2mg/mL are added mixes, and is protected from light, takes out at room temperature after 2h, is handled with the super filter tube of 50Kd, ultrafiltration
It is handled respectively with pure water and PBS buffer solution first in the process, the VEGF antibody for the acridinium ester label being eventually adding
Solution, collects liquid in centrifuge tube to saving pipe, packing be stored in 4 DEG C it is spare.
(5) preparation of VEGF standard items and calibration
In the present embodiment, international agreement reference material concentration is compareed by standard items raw material VEGF, goes out series with PBS doubling dilution
5 concentration points of standard items, and prepare S0 point.It is subject to working standard, this series of products standard items is surveyed with chemoluminescence method
Fixed each concentration point actual concentrations value, and each concentration point is finely tuned to target concentration value (0,50,100,200,400,800pg/mL),
Within calculating linearly dependent coefficient r=0.9992, accuracy 90%-110%.Standard is dispensed with the pipe-produced glass bottle of 2ml specification
Product solution, dispensed loading amount are 0.5ml/ bottles.It is placed in 2-8 DEG C of preservation.
(6) preparation of chemiluminescence preexciting liquid, chemiluminescence exciting liquid
(1) chemiluminescence preexciting liquid by mass fraction be 1% H2O2In solution be added 0.5wt% ethyl alcohol and
The Triton X-100 of 0.25wt% is made, 2-8 DEG C be kept in dark place it is spare.
(2) chemiluminescence exciting liquid by molar concentration be 1M NaOH solution in be added 0.5wt% ethyl alcohol and
The Tween-20 of 0.5wt% is made, 2-8 DEG C be kept in dark place it is spare.
(7) preparation of cleaning solution
Prepare pH 7.0, the phosphate buffer of 0.5mol/L, the buffer contain 10wt% Tween 20,
The Proclin 300 of 5wt%, 2-8 DEG C be kept in dark place it is spare.
(8) it detects
With electrochemical luminescence automatic lmunoassays analyzer (601 type of Roche Cobas e) for detection instrument, 50 μ are sequentially added
The VEGF antibody of the biotin labeling of L, the sample to be tested of 50 μ L, 50 μ L acridinium ester label VEGF antibody, make biotin mark
The final concentration of 0.1-2 μ g/ml of the VEGF antibody of note, the final concentration of 0.1-5 μ g/ml of the VEGF antibody of acridinium ester label, reaction
After 15min, the 20 μ L of Streptavidin magnetic particle that partial size is 1.5 μm is added, after reacting 5min, carries out Magneto separate, instrument will
Reaction mixture be sent into darkroom, sequentially add 100 μ L chemiluminescence preexciting liquid, 100 μ L chemiluminescence exciting liquids carry out it is luminous
Reaction, finally records luminous intensity, the content of sample is calculated from standard curve.
(9) kit performance detection
It is measured according to performance of the conventional kit performance detection mode to the kit, as a result as follows:
1, linearity test
Kit Plays product are taken, measure 3 times, is averaged, and as a result makees regression straight line with expected concentration, calculates at every
To regression coefficient r > 0.99, the range of linearity: 0-800pg/mL.
2, detection range
The VEGF standard items of the present embodiment have luminescence phenomenon, show this hair in the range of concentration is 0.1-10pg/ml
Bright kit detection range is 0.1-10pg/ml.
3, precision
In the kit batch and difference between batch is respectively less than 10%.
4, sensitivity
This kit is 3.5pg/mL to VEGF sensitivity for analysis.
5, stability: kit is stored in 2-8 DEG C of light protected environment, and validity period is 12 months;It uncaps and is stored in 2-8 DEG C and keeps away
In luminous environment, validity period is 30 days.
6, the rate of recovery: 90%-110%.
Finally, it should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations;Although
Present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that: it still may be used
To modify the technical solutions described in the foregoing embodiments or equivalent replacement of some of the technical features;
And these are modified or replaceed, technical solution of various embodiments of the present invention that it does not separate the essence of the corresponding technical solution spirit and
Range.
Claims (9)
1. a kind of detection kit of vascular endothelial growth factor, comprising: magnetic particle, the biotin mark of Streptavidin coupling
The VEGF antibody of note, the VEGF antibody of chemiluminescent labels label, VEGF standard items, chemiluminescence preexciting liquid, chemistry hair
Light exciting liquid, cleaning solution.
2. a kind of detection kit of vascular endothelial growth factor according to claim 1, which is characterized in that the chemistry
Luminous marker is acridinium ester or acridine ester derivant, and the acridine ester derivant includes acridinium ester acid-NHS ester, acridinic acid third
Sulfonate sodium or 9- azetidinecarboxylic acid.
3. a kind of detection kit of vascular endothelial growth factor according to claim 1, which is characterized in that the chemistry
Shine the Triton X- that preexciting liquid is the ethyl alcohol and mass percent 0.1-1% that are 0.1-1% containing mass percent
The mass fraction of 100 and/or Tween-20 is the H of 0.1-1%2O2Solution, the chemiluminescence exciting liquid are to contain quality percentage
The molar concentration of the Triton X-100 and/or Tween-20 of ethyl alcohol and mass percent 0.1-1% than 0.1-1% is
The NaOH solution of 0.05-lmol/L.
4. a kind of detection kit of vascular endothelial growth factor according to claim 1, which is characterized in that the strepto-
The magnetic particle of Avidin coupling by pH is 6-8, the phosphate buffer that molar concentration is 0.01-0.2mol/L or Tris buffering
Liquid is formulated, and partial size is 0.05-2 μm.
5. a kind of detection kit of vascular endothelial growth factor according to claim 1, which is characterized in that the magnetism
Particle core is ferroso-ferric oxide or di-iron trioxide, and the surface modification group of magnetic particle is carboxyl.
6. a kind of detection kit of vascular endothelial growth factor according to claim 1, which is characterized in that the VEGF
Standard items are that VEGF antigen sterling is added and is formulated using bovine serum albumin(BSA) buffer as solvent.
7. a kind of detection kit of vascular endothelial growth factor according to claim 6, which is characterized in that described
VEGF standard items are the VEGF standard items with multiple concentration gradients being made into.
8. a kind of detection kit of vascular endothelial growth factor according to claim 1, which is characterized in that the cleaning
Liquid includes the Triton X-100 and/or Tween 20 of mass percent 0.5-10%, pH 6-8, molar concentration 0.1-
The phosphate buffer or Tris buffer of 0.5mol/L and the Proclin 300 of mass percent 0.5-5%.
9. a kind of described in any item detection methods of the detection kit of vascular endothelial growth factor of claim 1-8 are used,
Include:
(1) the VEGF antibody for taking the VEGF antibody, sample to be tested, chemiluminescent labels of biotin labeling to mark is in reaction vessel
In, it mixes well, and in 37 DEG C of 10~30min of incubation, while preparing VEGF standard items;
(2) into reaction system be added Streptavidin coupling magnetic particle, mix well, and in 37 DEG C be incubated for 3~
10min, rear cleaning separation magnetic particle;The mixed of chemiluminescence preexciting liquid and chemiluminescence exciting liquid is added in magnetropism particle
Solution is closed, reacts and measures luminous intensity;
(3) standard curve is drawn according to VEGF standard concentration and luminous intensity, sample luminous intensity is corresponding on standard curve
Concentration value is the measurement concentration of sample to be tested.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811608343.0A CN109709336A (en) | 2018-12-26 | 2018-12-26 | A kind of detection kit and detection method of vascular endothelial growth factor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811608343.0A CN109709336A (en) | 2018-12-26 | 2018-12-26 | A kind of detection kit and detection method of vascular endothelial growth factor |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109709336A true CN109709336A (en) | 2019-05-03 |
Family
ID=66257826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811608343.0A Pending CN109709336A (en) | 2018-12-26 | 2018-12-26 | A kind of detection kit and detection method of vascular endothelial growth factor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109709336A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110082537A (en) * | 2019-04-17 | 2019-08-02 | 迪瑞医疗科技股份有限公司 | Vascular endothelial growth factor chemiluminescence immune detection reagent kit and preparation method thereof |
CN110208543A (en) * | 2019-06-06 | 2019-09-06 | 威海威高生物科技有限公司 | Vascular endothelial growth factor detection kit and its application method and application |
CN111044734A (en) * | 2019-12-30 | 2020-04-21 | 上海复星长征医学科学有限公司 | Detection kit for detecting vascular endothelial growth factor, and preparation method and use method thereof |
CN111808191A (en) * | 2020-05-11 | 2020-10-23 | 廊坊天光生物技术有限公司 | Antibody pair for detecting VEGF content in serum and application thereof |
CN112578128A (en) * | 2020-12-02 | 2021-03-30 | 苏州海狸生物医学工程有限公司 | Direct chemiluminescence kit for detecting content of beta-hCG and use method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105158235A (en) * | 2014-06-06 | 2015-12-16 | 厦门万泰凯瑞生物技术有限公司 | Enhanced acridinium ester luminescence system |
CN107561287A (en) * | 2017-08-30 | 2018-01-09 | 潍坊市康华生物技术有限公司 | A kind of vascular endothelial growth factor detection kit and its preparation and application |
CN107807241A (en) * | 2017-11-03 | 2018-03-16 | 太原瑞盛生物科技有限公司 | The magnetic microparticle chemiluminescence detection kit and preparation method of a kind of intravascular ErbB1 |
CN108490192A (en) * | 2018-03-27 | 2018-09-04 | 苏州长光华医生物医学工程有限公司 | Detect Mechano growth factor, the direct chemical luminescence reagent kit of its E peptide, preparation method |
-
2018
- 2018-12-26 CN CN201811608343.0A patent/CN109709336A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105158235A (en) * | 2014-06-06 | 2015-12-16 | 厦门万泰凯瑞生物技术有限公司 | Enhanced acridinium ester luminescence system |
CN107561287A (en) * | 2017-08-30 | 2018-01-09 | 潍坊市康华生物技术有限公司 | A kind of vascular endothelial growth factor detection kit and its preparation and application |
CN107807241A (en) * | 2017-11-03 | 2018-03-16 | 太原瑞盛生物科技有限公司 | The magnetic microparticle chemiluminescence detection kit and preparation method of a kind of intravascular ErbB1 |
CN108490192A (en) * | 2018-03-27 | 2018-09-04 | 苏州长光华医生物医学工程有限公司 | Detect Mechano growth factor, the direct chemical luminescence reagent kit of its E peptide, preparation method |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110082537A (en) * | 2019-04-17 | 2019-08-02 | 迪瑞医疗科技股份有限公司 | Vascular endothelial growth factor chemiluminescence immune detection reagent kit and preparation method thereof |
CN110208543A (en) * | 2019-06-06 | 2019-09-06 | 威海威高生物科技有限公司 | Vascular endothelial growth factor detection kit and its application method and application |
CN111044734A (en) * | 2019-12-30 | 2020-04-21 | 上海复星长征医学科学有限公司 | Detection kit for detecting vascular endothelial growth factor, and preparation method and use method thereof |
CN111808191A (en) * | 2020-05-11 | 2020-10-23 | 廊坊天光生物技术有限公司 | Antibody pair for detecting VEGF content in serum and application thereof |
CN112578128A (en) * | 2020-12-02 | 2021-03-30 | 苏州海狸生物医学工程有限公司 | Direct chemiluminescence kit for detecting content of beta-hCG and use method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109709336A (en) | A kind of detection kit and detection method of vascular endothelial growth factor | |
CN101949944B (en) | Triiodothyronine quantitative detection kit | |
US20080193955A1 (en) | Kit and Method for the Detection of Anti-Hepatitis C Virus (Hcv) Antibodies | |
US11592444B2 (en) | Detection of autoantibodies against the TSH receptor | |
CN104711279B (en) | It is prepared by a kind of VEGF detection kit and its raw material | |
CN108445222A (en) | A kind of kit and preparation method quantitatively detecting cardic fatty acid binding protein | |
WO2022193980A1 (en) | Antibody or antigen-binding fragment thereof for novel coronavirus nucleocapsid protein, and application thereof | |
CN102207504A (en) | Enzyme-linked immunosorbent assay kit, and preparation method thereof | |
BRPI0612666A2 (en) | monoclonal antibody, binding fragment, solid support, composition, hybridoma cell line, immunoassay and detection kits | |
CN110818800B (en) | Detection method for indirectly detecting target analyte by constructing bridged complex | |
CN109187971A (en) | Neuronspecific enolase chemiluminescence immune detection reagent kit and preparation method thereof | |
CN101949945B (en) | Kit for detecting free thyroxin by using magnetic particles as solid-phase carriers and preparation method thereof | |
CN101329343A (en) | New generation early diagnosis prostate gland cancer reagent kit and preparation method and detection process thereof | |
CN1979165A (en) | Alpha-fodrin antigen epi-position polypeptide mixture and its use | |
CN103969447A (en) | Vascular endothelial growth factor quantitative determination kit and light-emitting substrate solution thereof | |
ZA200600150B (en) | Reagents, methods and kits for detecting feed enzymes | |
CA2785678C (en) | Human insulin assay and assay reagent | |
CN110082537A (en) | Vascular endothelial growth factor chemiluminescence immune detection reagent kit and preparation method thereof | |
CN109239359A (en) | β 2-MG chemical luminescence immune assay determination reagent kit and preparation method thereof | |
EP1021721B1 (en) | Assays for tsh receptor autoantibodies | |
CN107746430B (en) | Preparation and application of GP 73C-terminal antigen | |
CN102435743B (en) | ELISA detection kit and preparation method thereof | |
CN103833859B (en) | New type of S mith chimeric peptide antigen and the application in laboratory diagnosis thereof | |
CN113376378A (en) | D-dimer detection kit, preparation method and application | |
CN112595845B (en) | Hyaluronic acid detection kit and detection system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190503 |